Continuing evolution of implantable cardioverter/defibrillators: Smaller size, longer life, improved cost-effectiveness

被引：0
|
作者：
Nisam, S [1 ]
机构：
[1] CPI, Guidant European Headquarters, B-1930 Zaventem, Belgium
来源：
CARDIAC ARRHYTHMIAS, PACING & ELECTROPHYSIOLOGY: THE EXPERT VIEW | 1998年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：295 / 300
页数：6
相关论文
共 50 条
  • [41] Pacemakers and implantable cardioverter defibrillators: Device longevity is more important than smaller size: The patient's viewpoint
    Wild, DM
    Fisher, JD
    Kim, SG
    Ferrick, KJ
    Gross, JN
    Palma, EC
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2004, 27 (11): : 1526 - 1529
  • [42] Cost-effectiveness of the implantable cardioverter defibrillator: Results from the Canadian Implantable Defibrillator Study (CIDS)
    O'Brien, B
    Connolly, S
    Goeree, R
    Blackhouse, G
    Willan, A
    Yee, R
    Roberts, R
    Gent, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 152A - 153A
  • [43] Cost-Effectiveness of Single-Chamber Compared with Dual-Chamber and Single-Lead with Atrial Sensing Implantable Cardioverter Defibrillators
    Hutton, David W.
    Harvey, Michael J.
    Thaker, Jay P.
    Freeman, James V.
    CIRCULATION, 2014, 130
  • [44] Economic Implications and Cost-effectiveness of Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy
    Bernard, Michael L.
    Gold, Michael R.
    HEART FAILURE CLINICS, 2011, 7 (02) : 241 - +
  • [45] Cost-effectiveness of the implantable cardioverter-defibrillator - Results from the Canadian Implantable Defibrillator Study (CIDS)
    O'Brien, BJ
    Connolly, SJ
    Goeree, R
    Blackhouse, G
    Willan, A
    Yee, R
    Roberts, RS
    Gent, M
    CIRCULATION, 2001, 103 (10) : 1416 - 1421
  • [46] COST-EFFECTIVENESS ANALYSIS OF SACUBITRIL/VALSARTAN IN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR ELIGIBLE PATIENTS
    Kaddoura, R.
    Abushanab, D.
    Arabi, A. R.
    Al-Badriyeh, D.
    VALUE IN HEALTH, 2022, 25 (07) : S419 - S419
  • [47] Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator the - Canadian Implantable Defibrillator Study
    Sheldon, R
    O'Brien, BJ
    Blackhouse, G
    Goeree, R
    Mitchell, B
    Klein, G
    Roberts, RS
    Gent, M
    Connolly, SJ
    CIRCULATION, 2001, 104 (14) : 1622 - 1626
  • [48] The effect of clinical risk stratification on the cost-effectiveness of the implantable cardioverter-defibrillator: The Canadian implantable defibrillator study
    Sheldon, RS
    O'Brien, B
    Blackhouse, G
    Goeree, R
    Mitchell, B
    Klein, G
    Roberts, R
    Gent, M
    Connolly, SJ
    CIRCULATION, 2001, 104 (17) : 345 - 345
  • [49] Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias - Results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) economic analysis substudy
    Larsen, G
    Hallstrom, A
    McAnulty, J
    Pinski, S
    Olarte, A
    Sullivan, S
    Brodsky, M
    Powell, J
    Marchant, C
    Jennings, C
    Akiyama, T
    CIRCULATION, 2002, 105 (17) : 2049 - 2057
  • [50] Can telemetric home monitoring of implantable defibrillators increase the treatment's cost-effectiveness ratio?
    Elsner, CH
    Dorszewski, A
    Kottkamp, H
    Schirdewahn, P
    Hindricks, G
    COMPUTERS IN CARDIOLOGY 2003, VOL 30, 2003, 30 : 193 - 196
12345